HIV-1 IN inhibitors: 2010 update and perspectives.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Current Topics in Medicinal Chemistry

• Publication date

  2009-07-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/156802609789630910PMID 19747122PMCID PMC2860603
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Scintillation proximity assays for mechanistic and pharmacological analyses of HIV-1 integration.

  2009cited by this paper
• Examination of halogen substituent effects on HIV-1 integrase inhibitors derived from 2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-ones and 4,5-dihydroxy-1H-isoindole-1,3(2H)-diones.

  2009cited by this paper
• Piecing together the structure of retroviral integrase, an important target in AIDS therapy

  2009cited by this paper
• Multimerization and DNA Binding Properties of INI1/hSNF5 and Its Functional Significance*

  2009cited by this paper
• Tricyclic HIV integrase inhibitors V. SAR studies on the benzyl moiety.

  2009cited by this paper
• HIV-1 integrase-hydrolyzing antibodies from sera of HIV-infected patients.

  2009cited by this paper
• Evolution of raltegravir resistance during therapy.

  2009cited by this paper
• Pharmacophore‐Based Discovery of Small‐Molecule Inhibitors of Protein–Protein Interactions between HIV‐1 Integrase and Cellular Cofactor LEDGF/p75

  2009cited by this paper
• Diketoacid-genre HIV-1 integrase inhibitors containing enantiomeric arylamide functionality.

  2009cited by this paper
• Quasispecies variant dynamics during emergence of resistance to raltegravir in HIV-1-infected patients.

  2009cited by this paper
• In search of small molecules blocking interactions between HIV proteins and intracellular cofactors.

  2009cited by this paper
• Piecing together the structure of retroviral integrase , an important target in AIDS therapy

  2009cited by this paper
• Complete Absolute Configuration of Integramide A, a Natural, 16‐mer Peptide Inhibitor of HIV‐1 Integrase, Elucidated by Total Synthesis

  2009cited by this paper
• Correlation between shiftide activity and HIV-1 integrase inhibition by a peptide selected from a combinatorial library.

  2008cited by this paper
• The total synthesis of fukiic acid, an HIV-1 integrase inhibitor.

  2008cited by this paper
• Preclinical Evaluation of GS-9160, a Novel Inhibitor of Human Immunodeficiency Virus Type 1 Integrase

  2008cited by this paper
• Comparison of raltegravir and elvitegravir on HIV-1 integrase catalytic reactions and on a series of drug-resistant integrase mutants.

  2008cited by this paper
• Safety, Tolerability, and Pharmacokinetics of Raltegravir After Single and Multiple Doses in Healthy Subjects

  2008cited by this paper
• Design and synthesis of dual inhibitors of HIV reverse transcriptase and integrase: introducing a diketoacid functionality into delavirdine.

  2008cited by this paper
• Synthesis and antiviral properties of some polyphenols related to Salvia genus.

  2008cited by this paper
• 2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-one-based HIV-1 integrase inhibitors.

  2008cited by this paper
• Anti-infectives: clinical progress of HIV-1 integrase inhibitors.

  2008cited by this paper
• Synthesis of pyrimidine and quinolone conjugates as a scaffold for dual inhibitors of HIV reverse transcriptase and integrase.

  2008cited by this paper
• Selection of diverse and clinically relevant integrase inhibitor-resistant human immunodeficiency virus type 1 mutants.

  2008cited by this paper
• The G140S mutation in HIV integrases from raltegravir-resistant patients rescues catalytic defect due to the resistance Q148H mutation

  2008cited by this paper
• Design, synthesis, and biological evaluation of a series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domain.

  2008cited by this paper
• Integrase inhibitors for the treatment of HIV infection.

  2008cited by this paper
• Novel Quinolinonyl Diketo Acid Derivatives as HIV-1 Integrase Inhibitors: Design, Synthesis, and Biological Activities

  2008cited by this paper
• Reaction of rosmarinic acid with nitrite ions in acidic conditions: discovery of nitro- and dinitrorosmarinic acids as new anti-HIV-1 agents.

  2008cited by this paper
• Nucleocapsid protein function in early infection processes.

  2008cited by this paper
• Mutations Associated with Failure of Raltegravir Treatment Affect Integrase Sensitivity to the Inhibitor In Vitro

  2008cited by this paper
• Broad Antiretroviral Activity and Resistance Profile of the Novel Human Immunodeficiency Virus Integrase Inhibitor Elvitegravir (JTK-303/GS-9137)

  2007cited by this paper
• Pharmacokinetics of Coadministered Ritonavir-Boosted Elvitegravir and Zidovudine, Didanosine, Stavudine, or Abacavir

  2007cited by this paper
• Molecular mechanisms of HIV integration and therapeutic intervention

  2007cited by this paper
• Rationally designed dual inhibitors of HIV reverse transcriptase and integrase.

  2007cited by this paper
• Changes to the HIV Long Terminal Repeat and to HIV Integrase Differentially Impact HIV Integrase Assembly, Activity, and the Binding of Strand Transfer Inhibitors*

  2007cited by this paper
• Characterization of a Replication-Competent, Integrase-Defective Human Immunodeficiency Virus (HIV)/Simian Virus 40 Chimera as a Powerful Tool for the Discovery and Validation of HIV Integrase Inhibitors

  2007cited by this paper
• Discovery of novel non-cytotoxic salicylhydrazide containing HIV-1 integrase inhibitors.

  2007cited by this paper
• Rapid and Durable Antiretroviral Effect of the HIV-1 Integrase Inhibitor Raltegravir as Part of Combination Therapy in Treatment-Naive Patients With HIV-1 Infection: Results of a 48-Week Controlled Study

  2007cited by this paper
• Interaction between HIV-1 Rev and Integrase Proteins

  2007cited by this paper
• Madurahydroxylactone Derivatives as Dual Inhibitors of Human Immunodeficiency Virus Type 1 Integrase and RNase H

  2007cited by this paper
• Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).

  2007cited by this paper
• Cellular Uptake of ODNs in HIV-1 Human-Infected Cells: A Role for Viral Particles in DNA Delivery?

  2007cited by this paper
• Investigation of Novel Lipid-Functionalized PNA Monomers as Potential HIV-1 Non-Nucleoside Reverse Transcriptase and/or Integrase Inhibitors

  2007cited by this paper
• HIV-1 integrase: from biology to chemotherapeutics.

  2007cited by this paper
• Caffeoylglycolic and caffeoylamino acid derivatives, halfmers of L-chicoric acid, as new HIV-1 integrase inhibitors.

  2007cited by this paper
• HIV integrase inhibitors as therapeutic agents in AIDS

  2007cited by this paper
• HIV-1 Integrase Inhibitors

  2007cited by this paper
• Probing HIV-1 Integrase Inhibitor Binding Sites with Position-Specific Integrase-DNA Cross-Linking Assays

  2007cited by this paper
• Selection of human immunodeficiency virus type 1 resistance against the pyranodipyrimidine V-165 points to a multimodal mechanism of action.

  2007cited by this paper
• Design of second generation HIV-1 integrase inhibitors.

  2007cited by this paper
• Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium

  2007cited by this paper
• Integration of human immunodeficiency virus as a target for antiretroviral therapy

  2006cited by this paper
• Novel HIV-1 integrase inhibitors derived from quinolone antibiotics.

  2006cited by this paper
• HIV‐1 integrase inhibitors: 2003–2004 update

  2006cited by this paper
• HIV-1 replication in cell lines harboring INI1/hSNF5 mutations

  2006cited by this paper
• Overexpression of the Lens Epithelium-Derived Growth Factor/p75 Integrase Binding Domain Inhibits Human Immunodeficiency Virus Replication

  2006cited by this paper
• Design, synthesis, and biological evaluation of chicoric acid analogs as inhibitors of HIV-1 integrase.

  2006cited by this paper
• Design, synthesis, and anti-integrase activity of catechol-DKA hybrids.

  2006cited by this paper
• A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex

  2006cited by this paper
• A historical sketch of the discovery and development of HIV-1 integrase inhibitors

  2006cited by this paper
• Integration Requires a Specific Interaction of the Donor DNA Terminal 5′-Cytosine with Glutamine 148 of the HIV-1 Integrase Flexible Loop*

  2006cited by this paper
• Mechanisms and inhibition of HIV integration.

  2006cited by this paper
• Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites

  2006cited by this paper
• Retroviral DNA integration: reaction pathway and critical intermediates

  2006cited by this paper
• Mode of inhibition of HIV-1 Integrase by a C-terminal domain-specific monoclonal antibody*

  2006cited by this paper
• Inhibition of Early Steps of HIV-1 Replication by SNF5/Ini1*

  2006cited by this paper
• Discovery of a small-molecule HIV-1 integrase inhibitor-binding site.

  2006cited by this paper
• Preferential Inhibition of the Magnesium-Dependent Strand Transfer Reaction of HIV-1 Integrase by α-Hydroxytropolones

  2006cited by this paper
• Transient and Stable Knockdown of the Integrase Cofactor LEDGF/p75 Reveals Its Role in the Replication Cycle of Human Immunodeficiency Virus

  2006cited by this paper
• Mass Spectrometric Analysis of the HIV-1 Integrase-Pyridoxal 5′-Phosphate Complex Reveals a New Binding Site for a Nucleotide Inhibitor*

  2005cited by this paper
• Integrase inhibitors to treat HIV/Aids

  2005cited by this paper
• An interlocked dimeric parallel-stranded DNA quadruplex: a potent inhibitor of HIV-1 integrase.

  2005cited by this paper
• Peptides Derived from the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 as Novel Inhibitors of the Viral Integrase*

  2005cited by this paper
• Synthesis and HIV-1 integrase inhibitory activities of caffeic acid dimers derived from Salvia officinalis.

  2005cited by this paper
• Inhibition of Human Immunodeficiency Virus Type 1 Reverse Transcriptase, RNase H, and Integrase Activities by Hydroxytropolones

  2005cited by this paper
• Targeting HIV-1 integrase with aptamers selected against the purified RNase H domain of HIV-1 RT.

  2005cited by this paper
• Interfacial inhibition of macromolecular interactions: nature's paradigm for drug discovery.

  2005cited by this paper
• Relationship between retroviral DNA-integration-site selection and host cell transcription.

  2005cited by this paper
• Interfacial inhibitors of protein-nucleic acid interactions.

  2005cited by this paper
• Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones

  2005cited by this paper
• Identification of an Evolutionarily Conserved Domain in Human Lens Epithelium-derived Growth Factor/Transcriptional Co-activator p75 (LEDGF/p75) That Binds HIV-1 Integrase*

  2004cited by this paper
• Structure and function of HIV-1 integrase.

  2004cited by this paper
• HIV-1 integrase complexes with DNA dissociate in the presence of short oligonucleotides conjugated to acridine.

  2004cited by this paper
• L-chicoric acid inhibits human immunodeficiency virus type 1 integration in vivo and is a noncompetitive but reversible inhibitor of HIV-1 integrase in vitro.

  2004cited by this paper
• A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase.

  2004cited by this paper
• HIV-1 integrase inhibitors: a decade of research and two drugs in clinical trial.

  2004cited by this paper
• Styrylquinolines, Integrase Inhibitors Acting Prior to Integration: a New Mechanism of Action for Anti-Integrase Agents

  2004cited by this paper
• Design and Synthesis of Novel Dihydroxyindole-2-Carboxylic Acids as HIV-1 Integrase Inhibitors

  2004cited by this paper
• Design and synthesis of novel indole beta-diketo acid derivatives as HIV-1 integrase inhibitors.

  2004cited by this paper
• Identification by phage display selection of a short peptide able to inhibit only the strand transfer reaction catalyzed by human immunodeficiency virus type 1 integrase.

  2004cited by this paper
• Nuclear Import of HIV-1 Integrase Is Inhibited in Vitro by Styrylquinoline Derivatives

  2004cited by this paper
• Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin.

  2004cited by this paper
• Integrase Inhibitors and Cellular Immunity Suppress Retroviral Replication in Rhesus Macaques

  2004cited by this paper
• The (52-96) C-terminal domain of Vpr stimulates HIV-1 IN-mediated homologous strand transfer of mini-viral DNA.

  2003cited by this paper
• Catechol-substituted L-chicoric acid analogues as HIV integrase inhibitors.

  2003cited by this paper
• Inhibition of HIV-1 Ribonuclease H by a Novel Diketo Acid, 4-[5-(Benzoylamino)thien-2-yl]-2,4-dioxobutanoic Acid*

  2003cited by this paper
• Design and synthesis of dimeric HIV-1 integrase inhibitory peptides.

  2003cited by this paper
• Metal-dependent inhibition of HIV-1 integrase by beta-diketo acids and resistance of the soluble double-mutant (F185K/C280S).

  2003cited by this paper
• NUCLEOSIDES, NUCLEOTIDES & NUCLEIC ACIDS, 20(4–7), 481–486 (2001) 6-OXOCYTIDINE CONTAINING OLIGONUCLEOTIDES INHIBIT THE HIV-1 INTEGRASE IN VITRO

  2003cited by this paper

• Isolation of New Chemical Modulators of the Interaction Between HIV-1 Integrase and the Cellular Restriction Factor GCN2

  2025cites this paper
• Target-based drug design strategies to overcome resistance to antiviral agents: opportunities and challenges.

  2024cites this paper
• Antiproliferative Effects of the Aptamer d(GGGT)4 and Its Analogues with an Abasic-Site Mimic Loop on Different Cancer Cells

  2022cites this paper
• Aptamers Against COVID-19: An Untested Opportunity

  2022cites this paper
• Aptamers for Anti-Viral Therapeutics and Diagnostics

  2021cites this paper
• HIV-1 Reverse Transcriptase/Integrase Dual Inhibitors: A Review of Recent Advances and Structure-activity Relationship Studies

  2021cites this paper
• HIV integrase inhibitors that inhibit strand transfer interact with RAG1 and hamper its activities.

  2021cites this paper
• Probing the Importance of the G-Quadruplex Grooves for the Activity of the Anti-HIV-Integrase Aptamer T30923

  2020cites this paper
• Recent advances in natural anti‐HIV triterpenoids and analogs

  2020cites this paper
• Characterization of Nine Compounds Isolated from the Acid Hydrolysate of Lonicera fulvotomentosa Hsu et S. C. Cheng and Evaluation of Their In Vitro Activity towards HIV Protease

  2019cites this paper
• Usage of central nervous system medication in HIV/AIDS patients: Longitudinal analysis (2005-2015) of prevalence and prescribing pattern changes

  2019cites this paper
• Anti-HIV activity of new higher order G-quadruplex aptamers obtained from tetra-end-linked oligonucleotides.

  2018cites this paper
• Cabotegravir in the treatment and prevention of Human Immunodeficiency Virus-1

  2018cites this paper
• Design, Synthesis, Molecular Modeling, In Silico ADME Studies and Anti-HIV-1 Assay of New Diazocoumarin Derivatives

  2018cites this paper
• Development of an HIV‐1 integrase genotyping assay for HIV‐1 subtype AE

  2018cites this paper
• Identification of spirocyclic or phosphate substituted quinolizine derivatives as novel HIV-1 integrase inhibitors: a patent evaluation of WO2016094197A1, WO2016094198A1 and WO2016154527A1

  2017cites this paper
• HIV integrase inhibitor, Elvitegravir, impairs RAG functions and inhibits V(D)J recombination

  2017cites this paper
• Effect of Cabotegravir on Cardiac Repolarization in Healthy Subjects

  2016cites this paper
• G-quadruplex-based aptamers against protein targets in therapy and diagnostics

  2016cites this paper
• Selectivity for strand-transfer over 3′-processing and susceptibility to clinical resistance of HIV-1 integrase inhibitors are driven by key enzyme–DNA interactions in the active site

  2016cites this paper
• 3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides Potently Inhibit HIV-1 Integrase and RNase H.

  2016cites this paper
• Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses

  2016cites this paper
• G-Quadruplex Forming Oligonucleotides as Anti-HIV Agents

  2015cites this paper
• Addressing the Issues of Non-isotropy and Non-additivity in the Development of Quantum Chemistry-Grounded Polarizable Molecular Mechanics

  2015cites this paper
• Metalloprotein Inhibitors for the Treatment of Human Diseases.

  2015cites this paper
• Stabilization of the integrase‐DNA complex by Mg2+ ions and prediction of key residues for binding HIV‐1 integrase inhibitors

  2014cites this paper
• Evaluation of the NIH clinical collection to identify potential HIV-1 integrase inhibitors

  2014cites this paper
• SURVEY AND SUMMARY G-quadruplexes in viruses: function and potential therapeutic applications

  2014cites this paper
• G-quadruplexes in viruses: function and potential therapeutic applications

  2014cites this paper
• Catalytic Mechanism of Retroviral Integrase for the Strand Transfer Reaction Explored by QM/MM Calculations.

  2014cites this paper
• Substituent-modulated affinities of halobenzene derivatives to the HIV-1 integrase recognition site. Analyses of the interaction energies by parallel quantum chemical and polarizable molecular mechanics.

  2014cites this paper
• Bicyclic 1-Hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-Containing HIV-1 Integrase Inhibitors Having High Antiviral Potency against Cells Harboring Raltegravir-Resistant Integrase Mutants

  2014cites this paper
• 4-Amino-1-hydroxy-2-oxo-1,8-naphthyridine-Containing Compounds Having High Potency against Raltegravir-Resistant Integrase Mutants of HIV-1

  2014cites this paper
• Specific features of HIV-1 integrase inhibition by bisphosphonate derivatives.

  2014cites this paper
• Potential Elucidation of a Novel CTL Epitope in HIV-1 Protease by the Protease Inhibitor Resistance Mutation L90M

  2013cites this paper
• Quantitative prediction of integrase inhibitor resistance from genotype through consensus linear regression modeling

  2013cites this paper
• Identification of potential HIV-1 integrase strand transfer inhibitors: In silico virtual screening and QM/MM docking studies

  2013cites this paper
• Computational design of a full-length model of HIV-1 integrase: modeling of new inhibitors and comparison of their calculated binding energies with those previously studied

  2013cites this paper
• Inhibitors of HIV-1 entry and integration: recent developments and impact on treatment.

  2013cites this paper
• Raltegravir flexibility and its impact on recognition by the HIV‐1 IN targets

  2013cites this paper
• The HIV-1 Integrase: Modeling and Beyond

  2013cites this paper
• Next-Generation Integrase Inhibitors

  2013influential citation
• Dynamics of the HIV infection under antiretroviral therapy: A cellular automata approach

  2013cites this paper
• Investigating the development and evolution of drug resistance in the HIV-1 pol gene

  2013cites this paper
• Design and synthesis of novel pyrimidone analogues as HIV-1 integrase inhibitors.

  2013cites this paper
• Impact of Resistance Mutations on Inhibitor Binding to HIV-1 Integrase

  2013cites this paper
• DNA Polymerases: Reverse Transcriptase Integrase, and Retrovirus Replication

  2013cites this paper
• Aromatic interaction profile to understand the molecular basis of raltegravir resistance

  2013cites this paper
• Exploring the Molecular Mechanism of Cross-Resistance to HIV-1 Integrase Strand Transfer Inhibitors by Molecular Dynamics Simulation and Residue Interaction Network Analysis

  2013cites this paper
• Cellular automata approach for the dynamics of HIV infection under antiretroviral therapies: The role of the virus diffusion

  2013cites this paper
• Activities, crystal structures, and molecular dynamics of dihydro-1H-isoindole derivatives, inhibitors of HIV-1 integrase.

  2013cites this paper
• The evaluation of gold-based compounds as potential inhibitors of HIV-1 replication.

  2012cites this paper
• Molecular Dynamics of HIV1-Integrase in Complex with 93del—A Structural Perspective on the Mechanism of Inhibition

  2012cites this paper
• 3′-Processing and strand transfer catalysed by retroviral integrase in crystallo

  2012cites this paper
• In vitro resistance selections using elvitegravir, raltegravir, and two metabolites of elvitegravir M1 and M4.

  2012cites this paper
• Development of polyphenols as HIV-1 integrase inhibitors: a summary and perspective.

  2012cites this paper
• In vitro evolution of an HIV integrase binding protein from a library of C-terminal domain γS-crystallin variants.

  2012cites this paper
• Nitrogen-containing polyhydroxylated aromatics as HIV-1 integrase inhibitors: synthesis, structure-activity relationship analysis, and biological activity

  2012cites this paper
• 6,7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing HIV-1 integrase inhibitors.

  2012cites this paper
• Recombinant rabbit single‐chain antibodies bind to the catalytic and C‐terminal domains of HIV‐1 integrase protein and strongly inhibit HIV‐1 replication

  2012cites this paper
• Unprocessed Viral DNA Could Be the Primary Target of the HIV-1 Integrase Inhibitor Raltegravir

  2012cites this paper
• Structural modifications of 5,6-dihydroxypyrimidines with anti-HIV activity.

  2012cites this paper
• Bicyclic Hydroxy‐1H‐pyrrolopyridine‐trione Containing HIV‐1 Integrase Inhibitors

  2012cites this paper
• Effect of a Single Supratherapeutic Dose of Dolutegravir on Cardiac Repolarization

  2012cites this paper
• A high-throughput assay for HIV-1 integrase 3'-processing activity using time-resolved fluorescence.

  2012cites this paper
• Novel potent antiviral molecules targeting the nucleocapsid protein of the HIV-1 virus

  2012cites this paper
• Probing chelation motifs in HIV integrase inhibitors

  2012influential citation
• HIV-Screening Strategies for the Discovery of Novel HIV-Inhibitors

  2011cites this paper
• Structural and Functional Analyses of the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir (S/GSK1349572)

  2011cites this paper
• MK-0536 Inhibits HIV-1 Integrases Resistant to Raltegravir

  2011cites this paper
• The study of susceptibility and resistance of HIV integrases to integrase strand transfer inhibitors and the development of novel single domain antibody targeting HIV integrase

  2011cites this paper
• Modelagem molecular de uma série de compostos inibidores da enzima integrase do vírus HIV-1

  2011cites this paper
• In-silico simulation towards anti-HIV drug discovery : A tool in the hour of need

  2011cites this paper
• 3-Hydroxypyrimidine-2,4-diones as an inhibitor scaffold of HIV integrase.

  2011cites this paper
• A Crystal Structure of the Catalytic Core Domain of an Avian Sarcoma and Leukemia Virus Integrase Suggests an Alternate Dimeric Assembly

  2011cites this paper
• Cross-resistance profile of the novel integrase inhibitor Dolutegravir (S/GSK1349572) using clonal viral variants selected in patients failing raltegravir.

  2011cites this paper
• Molecular Dynamics Approaches Estimate the Binding Energy of HIV-1 Integrase Inhibitors and Correlate with In Vitro Activity

  2011cites this paper
• HIV-1 integrase inhibitor T30177 forms a stacked dimeric G-quadruplex structure containing bulges

  2011cites this paper
• Yves Pommier and Activity In Vitro Inhibitors and Correlate with the Binding Energy of HIV-1 Integrase Molecular Dynamics Approaches Estimate

  2011cites this paper
• Development of tricyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors.

  2011cites this paper
• Interfacial inhibitors: targeting macromolecular complexes

  2011cites this paper
• Structural and functional analyses of the second-generation integrase strand transfer inhibitor Dolutegravir (S/GSK1349572)

  2011cites this paper
• Structure-Analysis of the HIV-1 Integrase Y143C/R Raltegravir Resistance Mutation in Association with the Secondary Mutation T97A

  2011cites this paper
• Elvitegravir overcomes resistance to raltegravir induced by integrase mutation Y143

  2011cites this paper
• Structure analysis of HIV-1 IN Y143C/R Raltegravir resistance mutation in association

  2011cites this paper
• ESCRT-II interacts with Staufen1 in mammalian cells and influences HIV-1 expression.

  2010cites this paper
• The evaluation of catechins that contain a galloyl moiety as potential HIV-1 integrase inhibitors.

  2010cites this paper
• Scaffold rearrangement of dihydroxypyrimidine inhibitors of HIV integrase: Docking model revisited.

  2010cites this paper
• Retroviral intasome assembly and inhibition of DNA strand transfer

  2010cites this paper
• Diversidade genética e resistência aos anti-retrovirais inibidores enzimáticos de vírus da imunodeficiência humana tipo 1 (HIV-1) de uma população de toxicodependentes por via endovenosa da Grande Lisboa

  2010cites this paper
• Biochemical and pharmacological analyses of HIV-1 integrase flexible loop mutants resistant to raltegravir.

  2010cites this paper
• Resistance to Integrase Inhibitors

  2010influential citation
• Blocking nuclear import of pre-integration complex: an emerging anti-HIV-1 drug discovery paradigm.

  2010cites this paper
• Computational investigation of the Anti-HIV activity of Chinese medicinal formula Three-Huang Powder

  2010cites this paper
• Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance

  2010cites this paper
• Authentic HIV-1 integrase inhibitors.

  2010cites this paper
• Computer tools in the discovery of HIV-1 integrase inhibitors.

  2010cites this paper
• Novel integrase inhibitors for HIV

  2010cites this paper
• The Interaction Between Lentiviral Integrase and LEDGF: Structural and Functional Insights

  2009cites this paper
• Infection and Drug Resistance Dovepress Patterns of Resistance Development with Integrase Inhibitors in Hiv

  year unknowncites this paper